-
-
-
-
-
-
-
Amylyx Pharmaceuticals inc. (AMLX) PT Raised to $22 at BofA Securities
-
-
-
-
-
-
-
Stifel Starts Amylyx Pharmaceuticals inc. (AMLX) at Buy
-
-
-
-
-
-
-
Amylyx Pharmaceuticals, Inc. (AMLX) Tops Q3 EPS by 8c
-
-
-
-
-
-
-
Amylyx Pharmaceuticals inc. (AMLX) PT Raised to $16 at BofA Securities
-
-
-
-
-
-
-
Citi on Amylyx Pharmaceuticals inc. (AMLX): 'we think avexitide is well positioned to demonstrate success'
-
-
-
-
-
-
-
Amylyx Pharmaceuticals (AMLX) Announces Positive Long-Term Results from Phase 2 HELIOS Trial of AMX0035
-
-
-
-
-
-
-
Amylyx Pharmaceuticals (AMLX) Announces FDA Has Lifted the Clinical Hold on AMX0114 Phase 1 Trial
-
446,721 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

